The fragile X syndrome is an X-linked mental retardation The identification of genes and their mutations has facilidisorder caused by an expanded CGG repeat in the first tated direct molecular diagnosis of numerous genetic exon of the fragile X mental retardation (FMR1) gene. Its disorders (McKusick 1995 Laxova 1995). The fragile X syndrome and reactions of (non)consenting parents/guardians were screening program presented here gives a model for acstudied by (pre-and posttest) questionnaires. A total of tively introducing a new DNA diagnostic procedure and, 2,189 individuals (65%) were eligible for testing, since they moreover, a method to obtain accurate prevalence data. had no valid diagnosis, cerebral palsy, or a previous test for The fragile X syndrome is characterized by X-linked the FMR1 gene mutation. Seventy percent (1,531/2,189) mental retardation with additional features such as a of the parents/guardians consented to testing. Besides 32 long face with large protruding ears, macroorchidism, previously diagnosed fragile X patients, 11 new patients (9 and eye-gaze avoidance (Fryns 1989; Hagerman 1996) . males and 2 females) were diagnosed. Scoring of physical Affected males and most of the affected females show a features was effective in preselection, especially for males fragile site at Xq27.3 in a percentage of the cells tested (sensitivity .91 and specificity .92). Major motives to partici-under special culture conditions (Sutherland and Hecht pate in the screening were the wish to obtain a diagnosis 1985); that method was used until the cloning of the (82%), the hereditary implications (80%), and the support gene. The first estimates of the prevalence of the fragile of research into mental retardation (81%). Thirty-four per-X syndrome, based on cytogenetic testing, were 1/ cent of the parents/guardians will seek additional diagnostic 1,000-1/2,600 for males and 1/2,000-1/4,000 for feworkup after exclusion of the fragile X syndrome. The males (Turner et al. 1986; Webb et al. 1986 ). prevalence of the fragile X syndrome was estimated at 1/ The cloning of the fragile X mental retardation 6,045 for males (95% confidence interval 1/9,981-1/ (FMR1) gene in 1991 (Oberlé et al. 1991; Verkerk et 3,851). On the basis of the actual number of diagnosed Yu et al. 1991) enabled an accurate molecular cases in the Netherlands, it is estimated that ú50% of the diagnosis. Affected individuals have expanded CGG refragile X cases are undiagnosed at present.
a premutation will transmit this, usually unaltered, to Intellectual functioning-profound/severe (IQ õ30), moderate (IQ 30-50), or mild mental retardation (IQ their daughters.
Screening for the fragile X syndrome by DNA analysis 50-70)-was established by each individual's psychologist, by IQ testing in schoolchildren, or by clinical estiwas offered to mentally handicapped individuals in schools and institutes for the mentally retarded in the mation in the institutionalized individuals. southwestern Netherlands. We analyzed the acceptance DNA Analysis by parents/guardians of mentally retarded individuals, A 10-ml blood sample was obtained from each indifeasibility of such a screening program, and the prevavidual, and genomic DNA was isolated from blood leulence of the fragile X syndrome in the Dutch population.
kocytes (Miller et al. 1988) . PCR analysis of the CGG The pre-and posttest attitudes and expectations of conrepeat was performed according to the method of Fu et senting and nonconsenting relatives were studied . al. (1991) , with modifications (van den Ouweland et al. 1994) . In all males without a fragment in the normal Patients and Methods range (6-54 CGG repeats) and for all females without Since 1992, a screening program for the fragile X two distinguishable normal fragments, additional syndrome has been conducted in 5 institutions giving Southern blot analysis on HindIII-digested DNA, using residential care (1,869 individuals aged 4-89 years, the intragenic probe pP2, was performed (Oostra et al. mean age 39.0 years) and 16 special schools (1,483 indi-1993) . viduals aged 5-21 years, mean age 13.0 years) for menQuestionnaires to Consenting and Nonconsenting tally retarded individuals in the southwestern NetherParents/Guardians lands. Persons without a known cause of their mental handicap, without cerebral palsy (with quadriplegia),
The acceptability of the screening program and the and without previous DNA-mutation analysis of the (anticipated) implications of test results was assessed in FMR1 gene (on the basis of medical records and previ-a pre-and posttest questionnaire study. A sample of ous medical investigations) were eligible for a brief phys-consenting parents/guardians (n Å 1,090) received a preical examination and venipuncture for DNA analysis of test questionnaire, after the blood sample was taken the FMR1 gene. Parents/guardians were informed by from their relative, and a posttest questionnaire, 3 wk letter and through information meetings. After the par-after the test result was obtained. A reminder was sent ents/guardians' written consent was obtained, the subafter 3 wk. Nonconsenters (n Å 435) received a quesjects were included in the study. Organizations for par-tionnaire to ask them about their motives. A translation ents/relatives were informed prior to the onset of the of the questionnaires is available on request. program. Also, the medical, nursing, and teaching staff Statistical Analysis of the various institutes and schools were informed in separate meetings. Parents/guardians of newly diagThe data were analyzed with version 6.0 of SPSS for nosed patients were offered genetic counseling and were Windows and the software Confidence Interval Analysis asked to participate in a follow-up study. The study (CIA) compiled by Gardner and Altman. The data are was approved by the Medical Ethical Committee of the presented as a proportion or percentage with a 95% Erasmus University and University Hospital Dijkzigt confidence interval (CI). Differences between groups (Rotterdam) and by the respective institutional ethical were assessed with the x 2 test, and the significance levels review committees.
(two tailed) will be presented.
Physical Examination
Results Each individual was scored by one of us for fragile X Study Population, Physical Examination, and features according to criteria of Laing et al. (1991) tion of the population prevalence is restricted to the data from males in this study because females with a full 61.6% -67.6%]). For 39 of the 3,352 individuals, the level of intellectual development could not be ascermutation in the FMR1 gene have an intellectual development varying from severely retarded to normal. The lattained, and those individuals were excluded in those analyses for which this level was required.
ter group was not included in this study among the mentally retarded. A total of 1,501 of the 1,531 tested individuals (including 11 with an unknown level of mental retardation who
In the group of mildly retarded males (n tot Å 602), 4 fragile X patients (f p ) were newly diagnosed among the are not included in table 1) had an CGG repeat in the normal range (õ43 repeats). For 12% of the males and participants (n p Å 333), for a relative prevalence (p p ) of .01201, and 6 fragile X patients (f ne ) had been previously 59% of the females, the PCR test result was inconclusive, and an additional Southern blot analysis was done. Al-diagnosed among the individuals who were not eligible for testing (n ne Å 108), for a relative prevalence (p ne ) of though no individuals with a premutation were detected, 19 individuals (1.2%) had an allele with a size in the .05555 (see table 3 ). If the relative prevalence in the nonparticipating group (n np Å 161) is assumed to be the ''intermediate range [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] , and among those was one female with an allele in the range of 55-60 CGG same as that in the participating group (namely, .01201), repeats. Further study was feasible in the families of nine the total prevalence in the sample of mildly retarded individuals (range 43-55 CGGs), and in those families neither instability of the CGG repeat nor fragile X patients could be detected. Eleven fragile X patients (0.7% [9 The prevalence of the fragile X syndrome was esti- guardians.-The response rate was 79% (860/1,090), (Maas et al. 1988) , one may expect 595 mildly retarded and most (71%) of the respondents were parents. fragile X males (F) in this population (95% CI 309-Eighty-four percent had discussed the DNA test with 1,038).
relatives and would inform them about the result. Major In the sample of moderately/severely retarded males motives to participate were the wish to have a diagnosis, (n tot Å 1,269), 5 fragile X patients (f p ) were newly diagthe hereditary implications, and the support of research nosed among the participants (n p Å 533), for a relative into mental retardation (table 4). Eighteen percent of prevalence (p p ) of .00938, and 24 fragile X patients (f ne ) the respondents (95% CI 15%-21%) expected that the had previously been diagnosed among the patients who fragile X syndrome would be diagnosed in their retarded were not eligible for testing (n ne Å 523), for a relative relative, 30% were uncertain (95% CI 27%-34%), and prevalence (p ne ) of .04589. If the relative prevalence in 52% did not expect the diagnosis (95% CI 48%-55%). the nonparticipating group (n np Å 213) is assumed to Six percent had intrusive thoughts and/or feelings about be the same as that in the participating group (namely, the test and its outcome (95% CI 5%-8%). Parents/ .00938), the total prevalence in the sample of moder-guardians of schoolchildren expected significantly more ately/severely retarded males (p tot ) is ([533/213]*.00938 often that a diagnosis would improve the care of their / [523*.04589])/1,269 Å .0244. With an estimate of retarded family member than did parents/guardians of 27,000 moderately/severely retarded males (N) in the institutionalized individuals (table 4) . Netherlands (95% CI 23,700-29,500) (Maas et al. Posttest attitude responses from consenting parents/ 1988), we estimated that the number of fragile X male guardians.-The response rate was 66% (681/1,030; a patients with a moderate/severe mental handicap (F) follow-up questionnaire could not be sent to 51 parents/ should be 660 fragile X male patients (95% CI 451-guardians, and the parents/guardians of the newly diag-932) in this population.
nosed were offered genetic counseling). One-third For the Netherlands, with 7,586,000 male residents (35%) of the respondents were relieved by the exclusion (Statistical yearbook of the Netherlands 1995), a total of the fragile X syndrome (95% CI 31%-38%). Oneof 1,255 males with the fragile X syndrome will result third (95% CI 29%-37%) were not relieved, and 5% in a prevalence of 1/6,045 for males (95% CI 1/9,981-(95% CI 3%-6%) were even disappointed. Eighteen 1/3,851). Varying the assumed relative prevalences in percent (95% CI 15%-21%) still worried about possithe nonparticipating group (half or double of the particible genetic implications for their family. The majority pating group) leads to prevalences for males that are (87%) had informed their relatives about the test result. 1/6,418 (95% CI 1/10,669-1/4,037) and 1/5,415 (95% After the exclusion of the fragile X syndrome in their CI 1/8,719-1/3,538), respectively. relative, the parents/guardians of schoolchildren were When a similar analysis is used for Down syndrome in significantly more willing to pursue further investigaour male study sample (20 mildly and 230 moderately/ tions, both actively and passively, than were the parents/ severely retarded males with Down syndrome), a preva-guardians of institutionalized individuals (table 4) . Relence of 1/1,288 for Down syndrome males was found spondents (80% [95% CI 77%-83%]) appreciated the (95% CI 1/1,538-1/1,087). This is similar to data from test and would recommend participation in such a prothe United Kingdom (Steele and Stratford 1995) . The gram to others. prevalence of the fragile X syndrome did not differ sigAttitude responses from nonconsenting parents/guardnificantly between the mildly retarded males and the ians.-The response rate was 35% (153/435). Nonconmoderately/severely retarded males (.0198 and .0244, senters differed only by having significantly higher education levels than consenters (those having at least a respectively).
/ 9a35$$se02
09-02-97 18:33:14 ajhgal UC-AJHG high school-level education were 64% [95% CI 56%-ably lower than the previously reported prevalence of 1/1,000-1/2,600 (Turner et al. 1986; Webb et al. 1986 ) 72%] and 47% [95% CI 43%-50%], respectively). The majority (78%) had discussed the DNA test with others. but is similar to more-recent reports of 1/4,000-1/5,000 (England and Australia) (Murray et al. 1996 ; Turner et The main reasons for nonconsenting were the opinion that a definite cause of the mental handicap in their al. 1996) . However, the sample sizes of these recent studies did not allow very accurate estimates; nor was relative was already known or the conviction that any possible cause must be different from the fragile X syna representative sampling of mentally retarded males achieved. The earlier high estimates were obtained by drome (table 4) . Significantly more often among nonconsenting parents of institutionalized persons, the test cytogenetic studies, with possible confounding either by other fragile sites in this region of the X chromosome was considered as too stressful for their relative (table  4) . Nonparticipation was neither influenced by fear of or by false positives (Turner et al. 1996) . The current estimate might be conservative; the relative prevalence in possible consequences of the test (9% [95% CI 4%-6%]) nor by religion (6% [95% CI 2%-12%]). Gener-the nonparticipating group might be variously estimated (see Results) but would minimally influence the estimate. ally, nonconsenters were not opposed to genetic testing (72% [95% CI 64%-80%]). One-third (95% CI 24%-Also, the PCR method is not 100% sensitive, since fragile X patients with mosaicism for a normal allele in 42%) even considered the future use of other diagnostic options if these would become available.
combination with a full mutation might be missed. However, these patients are very rare. In the Netherlands, among 7.6 million males, 1,255 Discussion males with the fragile X syndrome may be expected, probably without a difference between the distribution This first comprehensive genetic epidemiological in mildly retarded males and that in moderately/sestudy of a representative sample of male and female verely retarded males. However, the seven clinical gementally retarded individuals from a population (the netic centers, covering the whole country, identified Netherlands) of 15 1 10 6 inhabitants, using DNA tech-Ç450 male cases so far (B. A. Oostra, unpublished niques for the fragile X syndrome, indicates that the data). This suggests an underdiagnosis of ú50%. In prevalence of the fragile X syndrome in males in the general Dutch population is 1/6,045. This is considerour study, one-fourth of the fragile X patients were / 9a35$$se02 09-02-97 18:33:14 ajhgal UC-AJHG newly diagnosed cases. This study included both instition and informed their relatives, as was found elsewhere (Turner et al. 1992) . tutionalized (all ages) and noninstitutionalized (age õ21 years) but no noninstitutionalized adult retarded
The test procedure did not cause undue anxiety among the participants, and most were interested in fuindividuals. Most people in the latter group work in sheltered workshops and live either with their relatives ture diagnostic studies when these become available.
One-third of consenting parents/guardians arranged for or in sheltered homes. The fragile X syndrome is likely to be most underdiagnosed in this group, because of the additional diagnostic investigations and genetic counseling, as was reflected by a sharp increase in referrals for lack of diagnostically oriented medical care for these individuals. Improvement of genetic diagnosis in these clinical genetic and dysmorphological workup. The observations in the nonconsenting group should settings is important, also for counseling of the families. Selection of male patients for FMR1 gene analysis be interpreted with caution, given the low response. Reluctance was felt because of ''stressful'' blood sampling. might be facilitated by evaluation of dysmorphic features, since the presence of fragile X features was found That might be alleviated, in the future, by the FMR1 protein test, which requires only a few blood drops (Wilto increase 10-fold the yield of positive molecular diagnosis (table 2) . Such clinical preselection is less efficient lemsen et al. 1995) , or by a test using DNA isolated from a mouthwash or cheek brush (Hagerman et al. for females, because of the variability of expression of the full FMR1 mutation in females (Fryns 1989; Murray et al. 1996) . The majority of the nonconsenters believed that a ''definite'' cause for the handicap Hagerman 1996) .
Genetic carrier screening may be done at a young had already been established, however vague that diagnosis might have been. However, nonconsenters agreed adult age, especially to identify and inform female carriers of the pre-and full mutation prior to parenthood.
with the general principle of performing DNA and other diagnostic investigations among the mentally retarded. One study in the French Canadian population has suggested a 1/259 frequency of premutation-carrier feSeveral goals of a diagnostic program-that is, establishment of a cause for mental retardation and more males (Rousseau et al. 1995) . Alternatively, screening for the fragile X syndrome might start -as presented complete information and choice for parents and relatives-are obviously achieved in this study. Even in a here -among (young) mentally retarded individuals, which will allow families of newly diagnosed cases the northwestern European country with well-developed diagnostic facilities, ú50% of fragile X cases seem undiagoption of avoiding the birth of a subsequent affected child. However, genetic screening programs are under nosed at present. This reflects the slow rate of introduction of new diagnostic facilities in the care of the debate, for reasons of privacy, the risk of medicalization, the risk of losing insurance, and the lack of treatmentally handicapped. In a period of DNA technology and fears of genetic discrimination, this study shows that ment options. In the introduction of a screening program among the mentally retarded, a careful parents/guardians of individuals with mental handicaps have a realistic idea about potentials and limitations of assessment of the acceptability by the families directly involved is of primary importance. The present study new technologies, if they are adequately informed. The fear of health-care authorities and others regarding adshowed informed consent by parents or guardians in 71% of the eligible patients, which is in accordance verse effects of the study of larger groups of mentally handicapped individuals may be alleviated by the realiswith other reports (Jacobs et al. 1993; Hagerman et al. 1994; Slaney et al. 1995; Murray et al. 1996) . tic appraisal seen on the part of those directly involved. However, a high use of the test is only one of the parameters of acceptance. Motives for consenting
